UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
| (Mark One) |
| QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
| For the quarterly period ended |
or
| TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
| For the transition period from to |
Commission File Number:
Proto Labs, Inc.
(Exact name of registrant as specified in its charter)
| |
(State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) |
|
|
|
|
| |
(Address of principal executive offices) | (Zip Code) |
(
(Registrant’s telephone number, including area code)
Not Applicable
(Former name, former address and former fiscal year, if changed since last report)
Securities registered pursuant to Section 12(b) of the Act:
Title of each class | Trading Symbol(s) | Name of each exchange on which registered |
| |
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. ☑
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). ☑
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.
| ☑ | Accelerated filer | ☐ |
Non-accelerated filer | ☐ |
| |
Smaller reporting company | | Emerging growth company | |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date:
TABLE OF CONTENTS
Item |
|
Description |
|
Page |
|
|
|
|
|
1. |
|
|
||
2. |
|
Management's Discussion and Analysis of Financial Condition and Results of Operations |
|
|
3. |
|
|
||
4. |
|
|
||
1. |
|
|
||
1A. |
|
|
||
2. |
|
|
||
3. |
|
|
||
4. |
|
|
||
5. |
|
|
||
6. |
|
|
Item 1. Financial Statements
Proto Labs, Inc. |
Consolidated Balance Sheets |
(In thousands, except share and per share amounts) |
September 30, | December 31, | |||||||
2021 | 2020 | |||||||
(Unaudited) | ||||||||
Assets | ||||||||
Current assets | ||||||||
Cash and cash equivalents | $ | $ | ||||||
Short-term marketable securities | ||||||||
Accounts receivable, net of allowance for doubtful accounts of and as of September 30, 2021 and December 31, 2020, respectively | ||||||||
Inventory | ||||||||
Income taxes receivable | ||||||||
Prepaid expenses and other current assets | ||||||||
Total current assets | ||||||||
Property and equipment, net | ||||||||
Goodwill | ||||||||
Other intangible assets, net | ||||||||
Long-term marketable securities | ||||||||
Operating lease assets | ||||||||
Finance lease assets | ||||||||
Other long-term assets | ||||||||
Total assets | $ | $ | ||||||
Liabilities and shareholders' equity | ||||||||
Current liabilities | ||||||||
Accounts payable | $ | $ | ||||||
Accrued compensation | ||||||||
Accrued liabilities and other | ||||||||
Current contingent consideration | ||||||||
Current operating lease liabilities | ||||||||
Current finance lease liabilities | ||||||||
Total current liabilities | ||||||||
Long-term contingent consideration | ||||||||
Long-term operating lease liabilities | ||||||||
Long-term finance lease liabilities | ||||||||
Long-term deferred tax liabilities | ||||||||
Other long-term liabilities | ||||||||
Total liabilities | ||||||||
Shareholders' equity | ||||||||
Preferred stock, par value, authorized shares; issued and outstanding shares as of each of September 30, 2021 and December 31, 2020 | ||||||||
Common stock, par value, authorized shares; issued and outstanding and shares as of September 30, 2021 and December 31, 2020, respectively | ||||||||
Additional paid-in capital | ||||||||
Retained earnings | ||||||||
Accumulated other comprehensive loss | ( | ) | ( | ) | ||||
Total shareholders' equity | ||||||||
Total liabilities and shareholders' equity | $ | $ |
The accompanying notes are an integral part of these consolidated financial statements.
Proto Labs, Inc. |
Consolidated Statements of Comprehensive Income |
(In thousands, except share and per share amounts) |
(Unaudited) |
Three Months Ended | Nine Months Ended | |||||||||||||||
September 30, | September 30, | |||||||||||||||
2021 | 2020 | 2021 | 2020 | |||||||||||||
Statements of Operations: | ||||||||||||||||
Revenue | $ | $ | $ | $ | ||||||||||||
Cost of revenue | ||||||||||||||||
Gross profit | ||||||||||||||||
Operating expenses | ||||||||||||||||
Marketing and sales | ||||||||||||||||
Research and development | ||||||||||||||||
General and administrative | ||||||||||||||||
Total operating expenses | ||||||||||||||||
Income from operations | ||||||||||||||||
Other income (expense), net | ( | ) | ||||||||||||||
Income before income taxes | ||||||||||||||||
Provision for income taxes | ||||||||||||||||
Net income | $ | $ | $ | $ | ||||||||||||
Net income per share: | ||||||||||||||||
Basic | $ | $ | $ | $ | ||||||||||||
Diluted | $ | $ | $ | $ | ||||||||||||
Shares used to compute net income per share: | ||||||||||||||||
Basic | ||||||||||||||||
Diluted | ||||||||||||||||
Comprehensive Income (net of tax) | ||||||||||||||||
Comprehensive income | $ | ( | ) | $ | $ | $ |
The accompanying notes are an integral part of these consolidated financial statements. |
Proto Labs, Inc. |
Consolidated Statements of Shareholders' Equity |
(In thousands, except share amounts) |
Common Stock | Additional | Accumulated Other | ||||||||||||||||||||||
Paid-In | Retained | Comprehensive | ||||||||||||||||||||||
Shares | Amount | Capital | Earnings | Loss | Total | |||||||||||||||||||
Balance at January 1, 2021 | ( | ) | ||||||||||||||||||||||
Common shares issued on exercise of options and other, net of shares withheld for tax obligations | - | ( | ) | - | - | ( | ) | |||||||||||||||||
Common shares issued for Hubs acquisition | - | - | ||||||||||||||||||||||
Stock-based compensation expense | - | - | - | - | ||||||||||||||||||||
Repurchases of common stock | - | - | - | - | - | - | ||||||||||||||||||
Net income | - | - | - | - | ||||||||||||||||||||
Other comprehensive loss | ||||||||||||||||||||||||
Foreign currency translation adjustment | - | - | - | - | ( | ) | ( | ) | ||||||||||||||||
Net unrealized gains (losses) on investments in securities | - | - | - | - | ||||||||||||||||||||
Comprehensive loss | ( | ) | ||||||||||||||||||||||
Balance at March 31, 2021 | $ | $ | $ | $ | ( | ) | $ | |||||||||||||||||
Common shares issued on exercise of options and other, net of shares withheld for tax obligations | - | ( | ) | - | - | ( | ) | |||||||||||||||||
Stock-based compensation expense | - | - | - | - | ||||||||||||||||||||
Repurchases of common stock | ( | ) | - | ( | ) | ( | ) | - | ( | ) | ||||||||||||||
Net income | - | - | - | - | ||||||||||||||||||||
Other comprehensive income | ||||||||||||||||||||||||
Foreign currency translation adjustment | - | - | - | - | ||||||||||||||||||||
Net unrealized gains (losses) on investments in securities | - | - | - | - | ( | ) | ( | ) | ||||||||||||||||
Comprehensive income | ||||||||||||||||||||||||
Balance at June 30, 2021 | $ | $ | $ | $ | ( | ) | $ | |||||||||||||||||
Common shares issued on exercise of options and other, net of shares withheld for tax obligations | - | - | - | - | - | - | ||||||||||||||||||
Stock-based compensation expense | - | - | - | - | ||||||||||||||||||||
Repurchases of common stock | ( | ) | - | ( | ) | ( | ) | - | ( | ) | ||||||||||||||
Net income | - | - | - | - | ||||||||||||||||||||
Other comprehensive loss | ||||||||||||||||||||||||
Foreign currency translation adjustment | - | - | - | - | ( | ) | ( | ) | ||||||||||||||||
Net unrealized gains (losses) on investments in securities | - | - | - | - | ( | ) | ( | ) | ||||||||||||||||
Comprehensive loss | ( | ) | ||||||||||||||||||||||
Balance at September 30, 2021 | $ | $ | $ | $ | ( | ) | $ |
Common Stock | Additional | Accumulated Other | ||||||||||||||||||||||
Paid-In | Retained | Comprehensive | ||||||||||||||||||||||
Shares | Amount | Capital | Earnings | Loss | Total | |||||||||||||||||||
Balance at January 1, 2020 | ( | ) | ||||||||||||||||||||||
Common shares issued on exercise of options and other, net of shares withheld for tax obligations | ( | ) | ( | ) | ||||||||||||||||||||
Stock-based compensation expense | - | |||||||||||||||||||||||
Repurchases of common stock | ( | ) | ( | ) | ( | ) | ( | ) | ||||||||||||||||
Net income | - | |||||||||||||||||||||||
Other comprehensive income | ||||||||||||||||||||||||
Foreign currency translation adjustment | - | ( | ) | ( | ) | |||||||||||||||||||
Comprehensive income | ||||||||||||||||||||||||
Balance at March 31, 2020 | $ | $ | $ | $ | ( | ) | $ | |||||||||||||||||
Common shares issued on exercise of options and other, net of shares withheld for tax obligations | ||||||||||||||||||||||||
Stock-based compensation expense | - | |||||||||||||||||||||||
Repurchases of common stock | ( | ) | ( | ) | ( | ) | ( | ) | ||||||||||||||||
Net income | - | |||||||||||||||||||||||
Other comprehensive income | ||||||||||||||||||||||||
Foreign currency translation adjustment | - | |||||||||||||||||||||||
Comprehensive income | ||||||||||||||||||||||||
Balance at June 30, 2020 | $ | $ | $ | $ | ( | ) | $ | |||||||||||||||||
Common shares issued on exercise of options and other, net of shares withheld for tax obligations | ||||||||||||||||||||||||
Stock-based compensation expense | - | |||||||||||||||||||||||
Repurchases of common stock | - | |||||||||||||||||||||||
Net income | - | |||||||||||||||||||||||
Other comprehensive income | ||||||||||||||||||||||||
Foreign currency translation adjustment | - | |||||||||||||||||||||||
Comprehensive income | ||||||||||||||||||||||||
Balance at September 30, 2020 | $ | $ | $ | $ | ( | ) | $ |
The accompanying notes are an integral part of these consolidated financial statements. |
Proto Labs, Inc. |
Consolidated Statements of Cash Flows |
(In thousands) |
(Unaudited) |
Nine Months Ended | ||||||||
September 30, | ||||||||
2021 | 2020 | |||||||
Operating activities | ||||||||
Net income | $ | $ | ||||||
Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||
Depreciation and amortization | ||||||||
Stock-based compensation expense | ||||||||
Deferred taxes | ( | ) | ||||||
Amortization of marketable securities | ||||||||
Realized gain on available-sale-securities | ( | ) | ||||||
Fair value of contingent consideration | ( | ) | ||||||
Other | ( | ) | ||||||
Changes in operating assets and liabilities: | ||||||||
Accounts receivable | ( | ) | ( | ) | ||||
Inventories | ( | ) | ||||||
Prepaid expenses and other | ( | ) | ||||||
Income taxes | ( | ) | ( | ) | ||||
Accounts payable | ( | ) | ||||||
Accrued liabilities and other | ( | ) | ||||||
Net cash provided by operating activities | ||||||||
Investing activities | ||||||||
Purchases of property, equipment and other capital assets | ( | ) | ( | ) | ||||
Cash used for acquisitions, net of cash acquired | ( | ) | ||||||
Purchases of other assets and investments | ( | ) | ||||||
Purchases of marketable securities | ( | ) | ( | ) | ||||
Proceeds from sales of marketable securities | ||||||||
Proceeds from maturities of marketable securities | ||||||||
Net cash used in investing activities | ( | ) | ( | ) | ||||
Financing activities | ||||||||
Proceeds from exercises of stock options | ||||||||
Purchases of shares withheld for tax obligations | ( | ) | ( | ) | ||||
Repurchases of common stock | ( | ) | ( | ) | ||||
Principal repayments of finance lease obligations | ( | ) | ||||||
Net cash used in financing activities | ( | ) | ( | ) | ||||
Effect of exchange rate changes on cash and cash equivalents | ||||||||
Net decrease in cash and cash equivalents | ( | ) | ( | ) | ||||
Cash and cash equivalents, beginning of period | ||||||||
Cash and cash equivalents, end of period | $ | $ |
The accompanying notes are an integral part of these consolidated financial statements. |
Note 1 – Basis of Presentation
The unaudited interim Consolidated Financial Statements of Proto Labs, Inc. (Protolabs, the Company, we, us or our) have been prepared in accordance with accounting principles generally accepted in the United States of America (U.S. GAAP) for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. In the opinion of management, the accompanying financial statements reflect all adjustments necessary for a fair presentation of the Company’s statements of financial position, results of operations and cash flows for the periods presented. Except as otherwise disclosed herein, these adjustments consist of normal, recurring items. Operating results for interim periods are not necessarily indicative of results that may be expected for the fiscal year as a whole.
The preparation of the financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, expenses, and the related disclosures at the date of the financial statements and during the reporting period. Actual results could materially differ from these estimates. For further information, refer to the audited Consolidated Financial Statements and Notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2020 as filed with the Securities and Exchange Commission (SEC) on February 19, 2021.
The accompanying Consolidated Balance Sheet as of December 31, 2020 was derived from the audited Consolidated Financial Statements but does not include all disclosures required by U.S. GAAP for a full set of financial statements. This Form 10-Q should be read in conjunction with the Company’s Consolidated Financial Statements and Notes included in the Annual Report on Form 10-K filed on February 19, 2021 as referenced above.
Note 2 – Recent Accounting Pronouncements
Recently Adopted Accounting Pronouncements
In December 2019, the Financial Accounting Standards Board issued Accounting Standards Update (ASU) 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes (ASU 2019-12). ASU 2019-12 attempts to simplify aspects of accounting for franchise taxes and enacted changes in tax laws or rates, and clarifies the accounting for transactions that result in a step-up in the tax basis of goodwill. ASU 2019-12 is effective for public business entities for fiscal years beginning after December 15, 2020, including interim periods within that fiscal year. The Company adopted ASU 2019-12 on January 1, 2021 and there was no material impact on the Company’s consolidated financial statements.
Note 3 – Net Income per Common Share
Basic net income per share is computed based on the weighted-average number of common shares outstanding. Diluted net income per share is computed based on the weighted-average number of common shares outstanding, increased by the number of additional shares that would have been outstanding had potentially dilutive common shares been issued and reduced by the number of shares the Company could have repurchased from the proceeds from issuance of the potentially dilutive shares. Potentially dilutive shares of common stock include stock options, restricted stock units and restricted stock awards granted under stock-based compensation plans and shares committed to be purchased under the employee stock purchase plan. Performance stock units are excluded from the calculation of dilutive potential common shares until the performance conditions have been satisfied.
The table below sets forth the computation of basic and diluted net income per share:
Three Months Ended | Nine Months Ended | |||||||||||||||
September 30, | September 30, | |||||||||||||||
(in thousands, except share and per share amounts) | 2021 | 2020 | 2021 | 2020 | ||||||||||||
Net income | $ | $ | $ | $ | ||||||||||||
Basic - weighted-average shares outstanding: | ||||||||||||||||
Effect of dilutive securities: | ||||||||||||||||
Employee stock options and other | ||||||||||||||||
Diluted - weighted-average shares outstanding: | ||||||||||||||||
Net income per share: | ||||||||||||||||
Basic | $ | $ | $ | $ | ||||||||||||
Diluted | $ | $ | $ | $ |
Note 4 – Business Combinations
On January 22, 2021, the Company acquired all of the outstanding shares of 3D Hubs, Inc. (Hubs), for $
Hubs is based in Amsterdam, Netherlands and is a leading online manufacturing platform that provides customers with on-demand access to a global network of premium manufacturing partners. The acquisition enhances the Company’s value proposition by expanding the customer offerings, enabling the Company to more holistically serve its customers.
The fair value of the consideration paid for this acquisition has been allocated on a preliminary basis to the assets purchased and liabilities assumed based on their estimated fair values as of the acquisition date, with any excess recorded as goodwill. The goodwill associated with the acquisition represents both the strategic and growth opportunities by significantly expanding the customer offering with a network of premium manufacturing partners. The goodwill related to the acquisition is not deductible for tax purposes.
The Company recorded a contingent consideration liability of $
The results of Hubs since the date of acquisition have been included with Protolabs' results. Pro forma disclosures of the consolidated results of the Company with the full year effects of Hubs, as if the acquisition had occurred on January 1, 2020, are not required and have not been separately presented since the impact to the Company's results of operations was not material.
The acquisition has been accounted for under the acquisition method of accounting in accordance with ASC 805, Business Combinations. In the second quarter of 2021, the Company recorded adjustments to the preliminary allocation, including a $
(in thousands) | Acquisition | |||
Assets acquired: | ||||
Current assets | $ | |||
Intangible assets | ||||
Goodwill | ||||
Other long-term assets | ||||
Total assets acquired | ||||
Liabilities assumed: | ||||
Current contingent consideration | ||||
Current liabilities | ||||
Long-term contingent consideration | ||||
Long-term deferred tax liabilities | ||||
Other long-term liabilities | ||||
Total liabilities assumed | ||||
Net assets acquired | ||||
Cash paid | ||||
Cash acquired | ( | ) | ||
Net cash consideration | ||||
Equity portion of purchase price | ||||
Total purchase consideration | $ |
Note 5 – Goodwill and Other Intangible Assets
The changes in the carrying amount of goodwill during the nine months ended September 30, 2021 were as follows:
(in thousands) | Nine Months Ended September 30, 2021 | |||
Balance as of the beginning of the period | $ | |||
Goodwill acquired during the period | ||||
Foreign currency translation adjustments | ( | ) | ||
Balance as of the end of the period | $ |
Goodwill increased $
Intangible assets other than goodwill at September 30, 2021 and December 31, 2020 were as follows:
September 30, 2021 | December 31, 2020 | Useful | Weighted Average | |||||||||||||||||||||||||
(in thousands) | Gross | Accumulated Amortization | Net | Gross | Accumulated Amortization | Net | Life (in years) | Useful Life Remaining (in years) | ||||||||||||||||||||
Intangible assets with finite lives: | ||||||||||||||||||||||||||||
Marketing assets | $ | $( | ) | $ | $ | $( | ) | $ | ||||||||||||||||||||
Non-compete agreement | ( | ) | ( | ) | ||||||||||||||||||||||||
Software technology | ( | ) | ( | ) | ||||||||||||||||||||||||
Software platform | ( | ) | ||||||||||||||||||||||||||
Tradenames | ( | ) | ||||||||||||||||||||||||||
Customer relationships | ( | ) | ( | ) | ||||||||||||||||||||||||
Total intangible assets | $ | $ | ( | ) | $ | $ | $ | ( | ) | $ |
Intangible assets increased $
Estimated aggregated amortization expense based on the current carrying value of the amortizable intangible assets and current exchange rates is as follows:
(in thousands) | Estimated Amortization Expense | |||
Remaining 2021 | $ | |||
2022 | ||||
2023 | ||||
2024 | ||||
2025 | ||||
Thereafter | ||||
Total estimated amortization expense | $ |
Note 6 – Fair Value Measurements
Accounting Standards Codification, Fair Value Measurement (ASC 820), defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. ASC 820 also establishes a fair value hierarchy that requires classification based on observable and unobservable inputs when measuring fair value. There are three levels of inputs that may be used to measure fair value:
Level 1—Quoted prices in active markets for identical assets or liabilities.
Level 2—Observable inputs other than Level 1 prices such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.
Level 3—Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.
The Company's assets and liabilities that are required to be measured or disclosed at fair value on a recurring basis include cash and cash equivalents, marketable securities and contingent consideration. The Company’s cash consists of bank deposits. The Company’s cash equivalents measured at fair value consist of money market mutual funds. The Company determines the fair value of these investments using Level 1 inputs. The Company's marketable securities consist of short-term and long-term agency, municipal, corporate and other debt securities. Fair value for the corporate debt securities is primarily determined based on quoted market prices (Level 1). Fair values for the U.S. municipal securities, U.S. government agency securities, certificates of deposit and U.S. treasury securities are primarily determined using dealer quotes or quoted market prices for similar securities (Level 2). The Company's contingent consideration is the current fair value estimate of amounts owed to the former shareholders of Hubs and is determined using the Monte Carlo pricing model (Level 3).
The following table summarizes financial assets as of September 30, 2021 and December 31, 2020 measured at fair value on a recurring basis:
September 30, 2021 | December 31, 2020 | |||||||||||||||||||||||
(in thousands) | Level 1 | Level 2 | Level 3 | Level 1 | Level 2 | Level 3 | ||||||||||||||||||
Financial Assets: | ||||||||||||||||||||||||
Cash and cash equivalents | $ | $ | $ | $ | $ | $ | ||||||||||||||||||
Money market mutual fund | ||||||||||||||||||||||||
Marketable securities | ||||||||||||||||||||||||
Total | $ | $ | $ | $ | $ | $ | ||||||||||||||||||
Financial Liabilities: | ||||||||||||||||||||||||
Contingent consideration | $ | $ | $ | $ | $ | $ | ||||||||||||||||||
Total | $ | $ | $ | $ | $ | $ |
In the first quarter of 2021, the Company sold held-to-maturity securities in order to partially fund the acquisition of Hubs. As a result of the sale, all remaining marketable securities were reclassified to available-for-sale securities and reported at fair value.
The Company recorded a contingent consideration liability at the acquisition date of Hubs representing the amounts payable to former shareholders, as outlined under the terms of the merger agreement, payable subject to the satisfaction of performance-based targets during fiscal year 2021 and fiscal year 2022, consisting of up to $
Note 7 – Marketable Securities
The Company invests in short-term and long-term agency, municipal, corporate and other debt securities. As of September 30, 2021, the securities are categorized as available-for-sale and are recorded at fair value. As of December 31, 2020, the securities were categorized as held-to-maturity and were recorded at amortized cost, net of an allowance for credit losses. The change in categorization was a result of the sale of securities in the first quarter of 2021 in order to partially fund the acquisition of Hubs and did not have a material impact on our financial statements. The following table summarizes information regarding the Company’s short-term and long-term marketable securities as of September 30, 2021 and December 31, 2020:
September 30, 2021 | ||||||||||||||||
(in thousands) | Cost | Unrealized Gains | Unrealized Losses | Fair Value | ||||||||||||
U.S. municipal securities | $ | $ | $ | ( | ) | $ | ||||||||||
Corporate debt securities | ( | ) | ||||||||||||||
U.S. government agency securities | ( | ) | ||||||||||||||
Certificates of deposit/time deposits | ||||||||||||||||
Total marketable securities | $ | $ | $ | ( | ) | $ |
December 31, 2020 | ||||||||||||||||
(in thousands) | Cost | Unrealized Gains | Unrealized Losses | Fair Value | ||||||||||||
U.S. municipal securities | $ | $ | $ | ( | ) | $ | ||||||||||
Corporate debt securities | ( | ) | ||||||||||||||
U.S. government agency securities | ( | ) | ||||||||||||||
Certificates of deposit/time deposits | ||||||||||||||||
Commercial paper | ||||||||||||||||
Total marketable securities | $ | $ | $ | ( | ) | $ |
Fair values for the corporate debt securities are primarily determined based on quoted market prices (Level 1). Fair values for the U.S. municipal securities, U.S. government agency securities, certificates of deposit and U.S. treasury securities are primarily determined using dealer quotes or quoted market prices for similar securities (Level 2).
During the first quarter of 2020, the Company adopted the FASB ASU 2016-13, Financial Instruments – Credit Losses. The Company calculated the expected credit loss for each security in its portfolio using the probability-of-default method. The Company concluded the adoption of the guidance had no material impact on its consolidated financial statements.
Classification of marketable securities as current or non-current is based upon the security’s maturity date as of the date of these financial statements.
The September 30, 2021 balance of available-for-sale debt securities by contractual maturity is shown in the following table at fair value. Actual maturities may differ from contractual maturities because the issuers of the securities may have the right to prepay obligations without prepayment penalties.
September 30, | ||||
(in thousands) | 2021 | |||
Due in one year or less | $ | |||
Due after one year through five years | ||||
Total marketable securities | $ |
Note 8 – Inventory
Inventory consists primarily of raw materials, which are recorded at the lower of cost or market using the standard cost method, which approximates first-in, first-out (FIFO) cost. The Company periodically reviews its inventory for slow-moving, damaged and discontinued items and provides allowances to reduce such items identified to their recoverable amounts.
The Company’s inventory consisted of the following as of the dates indicated:
September 30, | December 31, | |||||||
(in thousands) | 2021 | 2020 | ||||||
Total inventory | $ | $ | ||||||
Allowance for obsolescence | ( | ) | ( | ) | ||||
Inventory, net of allowance | $ | $ |
Note 9 – Stock-Based Compensation
Under the Company’s 2012 Long-Term Incentive Plan, as amended (the 2012 Plan), the Company has the ability to grant stock options, stock appreciation rights (SARs), restricted stock, restricted stock units, other stock-based awards and cash incentive awards. Awards under the 2012 Plan have a maximum term of
years from the date of grant. The compensation committee may provide that the vesting or payment of any award will be subject to the attainment of specified performance measures in addition to the satisfaction of any continued service requirements and the compensation committee will determine whether such measures have been achieved. The per-share exercise price of stock options and SARs granted under the 2012 Plan generally may not be less than the fair market value of a share of our common stock on the date of the grant.
Employee Stock Purchase Plan
The Company’s 2012 Employee Stock Purchase Plan (ESPP) allows eligible employees to purchase a variable number of shares of the Company’s common stock each offering period at a discount through payroll deductions of up to
Stock-Based Compensation Expense
Stock-based compensation expense was $
Stock Options
The following table summarizes stock option activity during the nine months ended September 30, 2021:
Weighted- | ||||||||
Average | ||||||||
Stock Options | Exercise Price | |||||||
Options outstanding at December 31, 2020 | $ | |||||||
Granted | ||||||||
Exercised | ( | ) | ||||||
Forfeited | ( | ) | ||||||
Options outstanding at September 30, 2021 | $ | |||||||
Exercisable at September 30, 2021 | $ |
The outstanding options generally have a term of
years. For employees, options granted become exercisable ratably over the vesting period, which is generally a period of to years, beginning on the first anniversary of the grant date, subject to the employee’s continuing service to the Company. For the board of directors, options generally become exercisable in full on the first anniversary of the grant date.
The weighted-average grant date fair value of options that were granted during the nine months ended September 30, 2021 was $
The following table provides the assumptions used in the Black-Scholes pricing model valuation of options during the nine months ended September 30, 2021 and 2020:
Nine Months Ended September 30, | ||||||||
2021 | 2020 | |||||||
Risk-free interest rate | | | ||||||
Expected life (years) | ||||||||
Expected volatility | | | ||||||
Expected dividend yield | | |
As of September 30, 2021, there was $
Restricted Stock
Restricted stock awards are share-settled awards and restrictions lapse ratably over the vesting period, which is generally a period from
to years, beginning on the first anniversary of the grant date, subject to the employee's continuing service to the Company. For the board of directors, restrictions generally lapse in full on the first anniversary of the grant date.
The following table summarizes restricted stock activity during the nine months ended September 30, 2021:
Weighted- | ||||||||
Average | ||||||||
Grant Date | ||||||||
Restricted | Fair Value | |||||||
Stock | Per Share | |||||||
Restricted stock at December 31, 2020 | $ | |||||||
Granted | ||||||||
Restrictions lapsed | ( | ) | ||||||
Forfeited | ( | ) | ||||||
Restricted stock at September 30, 2021 | $ |
As of September 30, 2021, there was $
Performance Stock
Performance stock units (PSUs) are expressed in terms of a target number of PSUs, with anywhere between
The following table summarizes performance stock activity during the nine months ended September 30, 2021:
Weighted- | ||||||||
Average | ||||||||
Grant Date | ||||||||
Performance | Fair Value | |||||||
Stock | Per Share | |||||||
Performance stock at December 31, 2020 | $ | |||||||
Granted | ||||||||
Restrictions lapsed | ||||||||
Performance change | ( | ) | ||||||
Forfeited | ( | ) | ||||||
Performance stock at September 30, 2021 | $ |
The following table provides the assumptions used in the Monte Carlo pricing model valuation of PSUs during the nine months ended September 30, 2021 and 2020:
Nine Months Ended September 30, | ||||||||
2021 | 2020 | |||||||
Risk-free interest rate | | | ||||||
Expected life (years) | ||||||||
Expected volatility | | | ||||||
Expected dividend yield | | |
As of September 30, 2021, there was $
Employee Stock Purchase Plan
The following table presents the assumptions used to estimate the fair value of the ESPP during the nine months ended September 30, 2021 and 2020:
Nine Months Ended September 30, | ||||||||
2021 | 2020 | |||||||
Risk-free interest rate | | | ||||||
Expected life (months) | ||||||||
Expected volatility | | | ||||||
Expected dividend yield | | |
Note 10 – Accumulated Other Comprehensive Income (Loss)
Other comprehensive income (loss) is comprised of foreign currency translation adjustments and net unrealized gains (losses) on investments in securities. The following table presents the changes in accumulated other comprehensive income (loss) balances during the three and nine months ended September 30, 2021 and 2020:
Three Months Ended | Nine Months Ended | |||||||||||||||
September 30, | September 30, | |||||||||||||||
(in thousands) | 2021 | 2020 | 2021 | 2020 | ||||||||||||
Balance at beginning of period | $ | ( | ) | $ | ( | ) | $ | ( | ) | $ | ( | ) | ||||
Foreign currency translation adjustments | ||||||||||||||||
Other comprehensive income (loss) before reclassifications | ( | ) | ( | ) | ||||||||||||
Amounts reclassified from accumulated other comprehensive loss | ||||||||||||||||
Net current-period other comprehensive income (loss) | ( | ) | ( | ) | ||||||||||||
Net unrealized gains (losses) on investments in securities | ||||||||||||||||
Other comprehensive income (loss) before reclassifications | ( | ) | ||||||||||||||
Amounts reclassified from accumulated other comprehensive loss | ||||||||||||||||
Net current-period other comprehensive income (loss) | ( | ) | ||||||||||||||
Balance at end of period | $ | ( | ) | $ | ( | ) | $ | ( | ) | $ | ( |